Back

Long-term recurrence-free survival following second-generation cryoballoon ablation for persistent atrial fibrillation: role of the autonomic nervous system

7 April 2024 (08:30 - 15:00)
Organised by: Logo
Congress Presentation Part of: Atrial fibrillation: treatment 4 - ablation Rhythm Control, Catheter Ablation EHRA Premium Access EHRA 2024 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Doctor Denise Guckel

Heart and Diabetes Center NRW, Bad Oeynhausen (Germany)

8 More presentations in this session

Presentation thumbnail
Extended period rhythm outcomes of posterior box isolation of left atrium during pan-spectrum of atrial fibrillation catheter ablation in 4 randomized clinical trials
Doctor S. Lee (Seoul, KR)
Abstract Slides Video
Presentation thumbnail
Validation of the Castle HTx data in a real world scenario
Doctor C. Scheurlen (Cologne, DE)
Abstract Slides Video
Presentation thumbnail
Predictive value of guideline-referred risk scores in estimating left atrial low voltage areas and recurrence of atrial fibrillation in repeat ablation procedures
Doctor C. Georgi (Bernau, DE)
Abstract Slides Video
Presentation thumbnail
Radiofrequency balloon ablation: 1-year outcomes of the AURORA registry
Doctor I. My (Hamburg, DE)
Abstract Slides Video
Presentation thumbnail
Effectiveness of a novel integrated dilator-needle transseptal crossing device in atrial fibrillation cryoballoon ablation procedures.
Doctor J. Benezet Mazuecos (Madrid, ES)
Abstract Slides Video

Access the full session

Session thumbnail
Atrial fibrillation: treatment 4 - ablation

The Event

Event poster

EHRA 2024

7 April - 9 April 2024
You may be interested in
thumbnail
Congress Presentation
Are time and temperature profile of catheter cryoablation predictors of successful pulmonary vein isolation?
thumbnail
Congress Presentation
Effects of baroreceptor reflex modification on efficacy of ablation for atrial fibrillation
thumbnail
Congress Presentation
Impact of paroxysmal atrial fibrillation ablation on cardiac sympathetic nervous system: a prospective stratified randomized comparative study in patients with and without heart failure

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources